Suraj Mathew featured in Pharmaceutical Manufacturing

As today’s blockbuster and generic business models merge, experience and lessons learned in other industries can be used to refine this new model. A basic common tech transfer life science model can then be modified to fit individual company and regional variations in business strategy. Suraj Mathew’s article “Building a New Tech Transfer Model” discusses the need for tech transfer to change as the blockbuster and generic business models begin to merge.